Loading...
Adalimumab
India Pharmaceutical Trade Intelligence
Who Supplies Adalimumab to India from UNITED STATES
India's adalimumab imports from UNITED STATES total $167.7K across 27 shipments from 15 foreign suppliers. AGRACE PHARMA leads with $69.2K in import value; the top 5 suppliers together control 85.8% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for adalimumab — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
AGRACE PHARMA is the leading Adalimumab supplier from UNITED STATES to India, with import value of $69.2K across 3 shipments. The top 5 suppliers — AGRACE PHARMA, CELTIS HEALTHCARE LLC., M/S. CELTIS HEALTHCARE LLC, UNITED STATES PHARMACOPEIAL CONVENTION (USP), KREATIVE TECHNOLABS — collectively account for 85.8% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AGRACE PHARMA | $69.2K | 3 | 41.3% |
| 2 | CELTIS HEALTHCARE LLC. | $34.6K | 1 | 20.6% |
| 3 | M/S. CELTIS HEALTHCARE LLC | $19.7K | 2 | 11.7% |
| 4 | UNITED STATES PHARMACOPEIAL CONVENTION (USP) | $12.0K | 1 | 7.2% |
| 5 | KREATIVE TECHNOLABS | $8.4K | 6 | 5.0% |
| 6 | NEW LIFE MEDICALS (USA) INC. | $7.3K | 1 | 4.4% |
| 7 | SPRING BIO SOLUTIONS | $7.2K | 1 | 4.3% |
| 8 | M/S SEPTA PHARMACEUTICALS, INV. | $4.4K | 1 | 2.6% |
| 9 | EUROFINS LANCASTER LABORATORIES | $1.8K | 1 | 1.1% |
| 10 | CELONIC DEUTSCHLAND GMBH & cO KG | $1.4K | 1 | 0.9% |
| 11 | ichorbio Ltd | $652 | 1 | 0.4% |
| 12 | DIAGNOVATION TECHNOLOGIES INC. | $425 | 1 | 0.3% |
| 13 | ICHORBIO LTD | $333 | 1 | 0.2% |
| 14 | DIAGNOVATION TECHNOLOGIES INC | $198 | 1 | 0.1% |
| 15 | UNITED STATES PHARMACOPEIAL | $81 | 1 | 0.0% |
Showing top 15 of 15 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $69.0K | 3 | 41.2% |
| 2 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $39.0K | 2 | 23.2% |
| 3 | IPCA LABORATORIES LIMITED | $19.7K | 2 | 11.7% |
| 4 | ZYDUS LIFESCIENCES LIMITED | $14.7K | 2 | 8.8% |
| 5 | UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED | $12.1K | 2 | 7.2% |
| 6 | KRISHGEN BIOSYSTEMS | $9.3K | 8 | 5.6% |
| 7 | INTAS PHARMACEUTICALS LIMITED | $3.2K | 2 | 1.9% |
| 8 | BIOGENUIX MEDSYSTEMS PRIVATE LIMITED | $622 | 2 | 0.4% |
| 9 | BIOGENE INDIA | $6 | 1 | 0.0% |
| 10 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $3 | 1 | 0.0% |
| 11 | UNITED STATES PHARMACOPEIA INDIA PRIVATE LIMITED | $2 | 2 | 0.0% |
Import Statistics
- Import Value
- $167.7K
- Shipments
- 27
- Foreign Suppliers
- 15
- Indian Buyers
- 11
- Avg. Shipment
- $6.2K
Other Adalimumab Import Origins
Related Analysis
Frequently Asked Questions — Adalimumab Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Adalimumab suppliers from UNITED STATES to India?
The top Adalimumab suppliers from UNITED STATES to India include AGRACE PHARMA, CELTIS HEALTHCARE LLC., M/S. CELTIS HEALTHCARE LLC. The leading supplier is AGRACE PHARMA with import value of $69.2K USD across 3 shipments. India imported Adalimumab worth $167.7K USD from UNITED STATES in total across 27 shipments.
QHow much Adalimumab does India import from UNITED STATES?
India imported Adalimumab worth $167.7K USD from UNITED STATES across 27 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Adalimumab from UNITED STATES?
The main Indian buyers of Adalimumab sourced from UNITED STATES include MSN LABORATORIES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, IPCA LABORATORIES LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $69.0K in imports across 3 shipments.
QWhat is the total value of Adalimumab imports from UNITED STATES to India?
The total value of Adalimumab imports from UNITED STATES to India is $167.7K USD, across 27 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Adalimumab.
- 2.Supplier/Buyer Matching: 15 foreign suppliers from UNITED STATES and 11 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $167.7K aggregated from 27 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
27 Verified Shipments
15 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists